Published in Blood Weekly, February 21st, 2008
Target blood pressure control was achieved with Cleviprex, administered by intravenous (IV) infusion, by a median of 6.3 minutes for patients with RD and 11.3 minutes for patients with AHF, with 91 percent of RD patients (N=24) and 94 percent of AHF...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.